BE856937A - Compositions pharmaceutiques actives sur le systeme nerveux central - Google Patents

Compositions pharmaceutiques actives sur le systeme nerveux central

Info

Publication number
BE856937A
BE856937A BE179459A BE179459A BE856937A BE 856937 A BE856937 A BE 856937A BE 179459 A BE179459 A BE 179459A BE 179459 A BE179459 A BE 179459A BE 856937 A BE856937 A BE 856937A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
nervous system
central nervous
compositions active
active
Prior art date
Application number
BE179459A
Other languages
English (en)
French (fr)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of BE856937A publication Critical patent/BE856937A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE179459A 1976-07-20 1977-07-19 Compositions pharmaceutiques actives sur le systeme nerveux central BE856937A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7622045A FR2358881A1 (fr) 1976-07-20 1976-07-20 Composition pharmaceutique active sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
BE856937A true BE856937A (fr) 1978-01-19

Family

ID=9175888

Family Applications (1)

Application Number Title Priority Date Filing Date
BE179459A BE856937A (fr) 1976-07-20 1977-07-19 Compositions pharmaceutiques actives sur le systeme nerveux central

Country Status (3)

Country Link
BE (1) BE856937A (enrdf_load_stackoverflow)
FR (1) FR2358881A1 (enrdf_load_stackoverflow)
ZA (1) ZA774376B (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231099A (en) * 1991-04-15 1993-07-27 Du Pont Merck Pharmaceutical Company Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs

Also Published As

Publication number Publication date
ZA774376B (en) 1978-06-28
FR2358881A1 (fr) 1978-02-17
FR2358881B1 (enrdf_load_stackoverflow) 1980-10-03

Similar Documents

Publication Publication Date Title
FR2344287A1 (fr) Compositions pharmaceutiques anti-inflammatoires
NL7902778A (nl) Cerebraal werkzaam preparaat.
SE7709359L (sv) Farmaceutisk doseringsform
BE851590A (fr) Compositions pharmaceutiques renfermant des pyrethrinoides
IT7830708A0 (it) Composti farmacologicamente attivi.
IT7919107A0 (it) Composti farmacologicamente attivi.
NO144444C (no) Fortillegg for droevtyggere.
NL7600906A (nl) Farmacologisch actieve verbindingen.
FI773568A7 (fi) Farmaceutiska preparat med laongtidsverkan
NL980017I1 (nl) Anti-hypertensief oraal farmaceutisch preparaat.
NL7714432A (nl) 1-gesubstitueerde-3-aminoethoxypyrrolidinen met geneeskrachtige activiteit.
NL7613093A (nl) Farmacologisch actieve verbindingen.
NL7705561A (nl) Farmaceutisch preparaat en werkwijzen voor de bereiding en toepassing ervan.
NL7708379A (nl) Farmacologisch actieve verbindingen.
BE856937A (fr) Compositions pharmaceutiques actives sur le systeme nerveux central
IT7828531A0 (it) (omega-amminoalcossi) dibenzili farmaceuticamente attivi.
DD128671A5 (de) Pharmazeutische mittel
NL7708916A (nl) Inrichting voor meervoudige dosering.
NL7805158A (nl) Farmaceutisch preparaat.
NL7705560A (nl) Farmaceutisch preparaat.
NL7614500A (nl) Montmorilloniet bevattende farmaceutische preparaten.
NL7812344A (nl) Farmaceutisch preparaat.
SE7607120L (sv) Dosinstellare
NL7712100A (nl) Farmaceutische preparaten.
NL7709334A (nl) Carcinostatisch preparaat.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SYNTHELABO

Effective date: 19840719